Oncotelic Therapeutics (OTLC) Operating Expenses (2010 - 2026)
Oncotelic Therapeutics (OTLC) posted Operating Expenses of $1.09 million for Q2 2026, compared with $65,969 a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Operating Expenses (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Operating Expenses at Oncotelic Therapeutics was $4.18 million, up 20.1% year-over-year; for FY2025, it was $3.19 million, down 10.9% from FY2024.
- Annual Operating Expenses has declined for three consecutive years, with a five-year compound annual growth rate of -19.3% (FY2020 to FY2025).
- In prior years, Oncotelic Therapeutics' Operating Expenses was $3.58 million in FY2024 (-46.8%), $6.72 million in FY2023 (-30.9%), $9.72 million in FY2022 (+6.5%) and $9.13 million in FY2021 (-2.1%).
- Quarterly Operating Expenses has run from a low of $31,454 in Q4 2024 to a high of $6.32 million in Q2 2023 over five years.
- The strongest year-over-year quarter for Operating Expenses in the past five years was Q4 2022, with growth of 198.8%; the weakest was Q2 2024, with a decline of 98.5%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 7.95 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 10.12 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 10.56 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 12.80 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 6.09 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 9.70 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 6.54 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 18.20 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 6.68 Bn |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - | 1.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.09 Mn |
| Dec 31, 2025 | 2.53 Mn |
| Sep 30, 2025 | 490,973.00 |
| Jun 30, 2025 | 65,969.00 |
| Mar 31, 2025 | 101,100.00 |
| Dec 31, 2024 | 31,454.00 |
| Sep 30, 2024 | 3.28 Mn |
| Jun 30, 2024 | 96,582.00 |
| Mar 31, 2024 | 167,222.00 |
| Dec 31, 2023 | 113,463.00 |
| Sep 30, 2023 | 55,522.00 |
| Jun 30, 2023 | 6.32 Mn |
| Mar 31, 2023 | 264,116.00 |
| Dec 31, 2022 | 4.53 Mn |
| Sep 30, 2022 | 595,439.00 |
| Jun 30, 2022 | 256,315.00 |
| Mar 31, 2022 | 4.34 Mn |
| Dec 31, 2021 | 1.51 Mn |
| Sep 30, 2021 | 1.81 Mn |
| Jun 30, 2021 | 3.76 Mn |
API Access
Oncotelic Therapeutics Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();